Table 4. Prevalence of persistent antiphospholipid antibodies (aPL) defined as 2 positive test results >12 weeks apart in abdominal aortic aneurysm (AAA) patients.

aPL double-positivity [%]	6/9 (66.7%)
aPL subsets, n (%*)	3 (50%) CL IgG+
	1 (16.7%) CL & β2GPI IgG+
	1 (16.7%) CL IgM+
	1 (16.7%) CL & β2GPI IgM+

Nine of 13 patients with a positive test result underwent a second antibody testing.

β2GPI, β2 glycoprotein I antibodies; CL, cardiolipin antibodies.

*out of aPL-positive patients.